GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract W15QKN21C0014REGENERON PHARMACEUTICALS INC

Overview

Award facts

Net obligations
$5.57B
$5,565,000,000of $5.57B potential value
Period of performance
Jan 12, 2021 to Jul 31, 2022
Ended
Modifications
7
Latest action Jul 29, 2022
Contract type
Definitive contract
PIID W15QKN21C0014

Description of requirement

PRODUCTION OF THERAPEUTIC IN SUPPORT OF NATIONAL EMERGENCY RESPONSE TO CORONAVIRUS 2019 (COVID-19): IN SUPPORT OF OPERATION WARP SPEED (OWS), THE GOVERNMENT IS PURCHASING UP TO 1,250,000 DOSES OF THE EMERGENCY USE AUTHORIZATION (EUA) THERAPEUTIC.

Dates and value

Award date
Signed on Jan 12, 2021
Potential end of performance
Jul 30, 2022
Current value
$5,565,000,000Base and exercised options
Potential value (if all options are exercised)
$5,565,000,000

Obligations by fiscal year of action

  • FY2021: $5,565,000,000

Total across 1 fiscal year: $5,565,000,000

The Department of Defense funded and awarded this contract. DoD contract actions are withheld at the source for about 90 days after signature, so actions signed after Aug 16, 2026 are not yet public.

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 29, 2022. View on USAspending · Recipient on SAM.gov

Recipient

LocationTARRYTOWN, NY
UEIN3F9MH7E6HD6
CAGE code544P9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationCorporation (not tax-exempt)Manufacturer of goods

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Defense
  2. Department Of The Army
  3. W6QK ACC-APG NATICK
Funded by
  1. Department of Defense
  2. Department Of The Army
  3. W6DZ JPMO CBD JPMO MCS (06)

Place of performance

Place of performance
Tarrytown, Westchester County, New York 10591-6717
Congressional district (place of performance)
NY-17As reported at the time of the action

Classification and competition

Classification

Product or service (PSC)
6505DRUGS AND BIOLOGICALS (product)

Competition

Extent competed
Not competedC
Reason not competed
Urgency (FAR 6.302-2)URG
Solicitation procedures
Only one sourceSSS
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
1

Solicitation and notices

Solicitation ID
W15QKN21R0047(as reported)
Solicitation date
Dec 23, 2020

Contract details

Subcontracting plan
Commercial subcontract planG
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jan 12, 2021Base obligation at award: $2,625,000,000
Latest action
Jul 29, 2022 — Supplemental agreement (within scope)Modification P00007
Latest substantive action
Jul 29, 2022 — Supplemental agreement (within scope)Modification P00007
Actions by type
  • Base award1
  • Supplemental agreement (within scope)3
  • Other administrative action2
  • New work added (outside scope)1
  • Change order1
8 actions recorded, Jan 12, 2021 to Jul 29, 2022; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
National interest action
COVID-19 2020P20C
Contingency, humanitarian or peacekeeping operation
Presidential issued emergency declaration, or a major disaster declarationC

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Mfg in U.S.D
Sea transportation
No

Structure

Award or IDV
Award
Award type
Definitive contractD
IT commercial item category
Not IT products or servicesZ
DoD claimant program
All others not identifiable to any other procurement programC9E
Awarding agency code
9700
Awarding sub-tier code
2100
Contracting office code
W58P05
Transactions recorded under this award key
8

Funding

Funding agency code
9700
Funding sub-tier code
2100
Funding office code
W56XNH